There is 1 paper on potassium time-in-target range in aging research: 1 observational study in people.
1 paper studies it3 findings
1 new paper in 30 daysSee all 1 papers on potassium time-in-target range
“Doubling in potassium TIR was associated with a 20% lower risk of the composite outcome (HR 0.80, 95% CI 0.70-0.92, P=0.001).”
- Humans1
Interventions
1Finerenone
upin humans1
1 study
Finerenone
upin humans1
Finerenone increases potassium time-in-target range in humans (Compared with placebo; potassium target range 4.5-5.0 mmol/L) (8% (95% CI 7-9); median 38% vs. 23%).
“Randomization to finerenone increased TIR by 8% (95% CI 7-9) compared with placebo”
Human trialCompared with placebo; potassium target range 4.5-5.0 mmol/Lfirst year35% womensn = 18,991
AHA Scientific Sessions 2026 abstract
Associations
2Cardiovascular death
downin humans1
1 study
Cardiovascular death
downin humans1
Potassium time-in-target range is associated with cardiovascular death in humans (Higher time within serum potassium range 4.5-5.0 mmol/L) (P=0.042).
“which appeared driven by lower risks of CV death (P=0.042; Fig 2B) compared with HF hospitalization (P=0.23; Fig 2C).”
HumansHigher time within serum potassium range 4.5-5.0 mmol/LTime-in-target range during the first year; subsequent outcomes35% womensn = 18,991
AHA Scientific Sessions 2026 abstract
First heart failure hospitalization or cardiovascular death
downin humans1HR 0.8
1 study
First heart failure hospitalization or cardiovascular death
downin humans1HR 0.8
Potassium time-in-target range is associated with first heart failure hospitalization or cardiovascular death in humans (Per doubling of time within serum potassium range 4.5-5.0 mmol/L) (20% lower risk per doubling; HR 0.80, 95% CI 0.70-0.92, P=0.001).
“Doubling in potassium TIR was associated with a 20% lower risk of the composite outcome (HR 0.80, 95% CI 0.70-0.92, P=0.001).”
HumansPer doubling of time within serum potassium range 4.5-5.0 mmol/LTime-in-target range during the first year; subsequent outcomes35% womensn = 18,991
AHA Scientific Sessions 2026 abstract